文献速递多重用药衰弱、肌少症与跌倒认知障碍与谵妄

持续药师服务减少养老机构药物性恶化与不良反应的多中心随机对照试验

Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).
PubMed 文献 · Age Ageing · 2022-01-01

该多中心开放标签平行随机对照试验在39家澳大利亚养老机构中评估药师主导的干预(使用经验证工具每8周一次、持续12个月)能否减少药物性恶化与不良反应。248名居民完成研究,主要结局衰弱指数变化组间无统计学显著差异,认知功能出现显著组间差异,其他次要结局无显著差异。

要点

  • 药师主导干预未显著改善12个月衰弱指数变化。
  • 干预组12个月认知评分变化显著优于对照组。
  • 24小时运动行为、握力、不良事件及生活质量无显著组间差异。

核心结论

  • 使用经验证工具检测药物性恶化迹象的药师实践模式需进一步研究,本试验结果有前景,尤其在认知改善方面。

研究设计与样本

  • 多中心、开放标签、平行随机对照试验,涉及39家澳大利亚养老机构。
  • 纳入居民需使用≥4种药物或≥1种抗胆碱能或镇静药物。
  • 248人完成研究,干预组120人、对照组128人,中位年龄87岁。
  • 干预组共进行575次药师会话,干预每8周一次、持续12个月;对照为常规住宿药物管理审查。

主要发现

  • 12个月衰弱指数变化组间无统计学显著差异(均差0.009,95%CI -0.028至0.009,P=0.320)。
  • 12个月认知评分变化组间显著差异(均差1.36分,95%CI 0.01至2.72,P=0.048)。
  • 24小时运动行为、握力、不良事件及生活质量变化组间无显著差异。
  • 12个月时衰弱、24小时运动行为及握力的点估计值偏向干预组。

关键数值与推荐

  • 主要结局为12个月衰弱指数变化。
  • 次要结局包括认知、加速度计24小时运动行为、握力、体重、不良事件及生活质量变化。

临床怎么用

  • 药师可使用经验证工具每8周检测药物性恶化迹象,但该模式对衰弱等硬结局的获益尚需进一步研究证实。
  • 认知改善的初步信号提示该干预可能对养老机构居民认知有潜在益处。

局限性

  • 开放标签设计可能引入偏倚。
  • 完成研究样本248人,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effectiveness of a pharmacist-led intervention using validated tools to reduce medicine-induced deterioration and adverse reactions. DESIGN AND SETTING: Multicenter, open-label parallel randomised controlled trial involving 39 Australian aged-care facilities. PARTICIPANTS: Residents on ≥4 medicines or ≥1 anticholinergic or sedative medicine. INTERVENTION: Pharmacist-led intervention using validated tools to detect signs and symptoms of medicine-induced deterioration which occurred every 8 weeks over 12 months. COMPARATOR: Usual care (Residential Medication Management Review) provided by accredited pharmacists. OUTCOMES: Primary outcome was change in Frailty Index at 12 months. Secondary outcomes included changes in cognition, 24-hour movement behaviour by accelerometry, grip strength, weight, adverse events and quality of life. RESULTS: 248 persons (median age 87 years) completed the study; 120 in the interventionand, 128 in control arms. In total 575 pharmacist, sessions were undertaken in the intervention arm. There was no statistically significant difference for change in frailty between groups (mean difference: 0.009, 95% CI: -0.028, 0.009, P = 0.320). A significant difference for cognition was observed, with a mean difference of 1.36 point change at 12 months (95% CI: 0.01, 2.72, P = 0.048). Changes in 24-hour movement behaviour, grip strength, adverse events and quality of life were not significantly different between groups. Point estimates favoured the intervention arm at 12 months for frailty, 24-hour movement behaviour and grip strength. CONCLUSIONS: The use of validated tools by pharmacists to detect signs of medicine-induced deterioration is a model of practice that requires further research, with promising results from this trial, particularly with regards to improved cognition.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Roughead EE, Pratt NL, Parfitt G, et al. Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial). Age Ageing. 2022. PMID: 35460410. doi:10.1093/ageing/afac092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。